Management of Erectile Dysfunction: An Under-recognition of Hypertension

Koroglu G., KAYA SEZGİNER E., YILMAZ ORAL D., GÜR S.

CURRENT PHARMACEUTICAL DESIGN, cilt.24, sa.30, ss.3506-3519, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 24 Sayı: 30
  • Basım Tarihi: 2018
  • Doi Numarası: 10.2174/1381612824666180828104350
  • Dergi Adı: CURRENT PHARMACEUTICAL DESIGN
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.3506-3519
  • Anahtar Kelimeler: Antihypertensive treatment, endothelial dysfunction, erectile dysfunction, hypertension, phosphodiesterase-5 inhibitors, high blood pressure, QUALITY-OF-LIFE, NITRIC-OXIDE SYNTHASE, PENILE CORPUS CAVERNOSUM, CARDIOVASCULAR RISK-FACTORS, PROGENITOR CELLS CORRELATE, AMBULATORY BLOOD-PRESSURE, II RECEPTOR-BLOCKER, C-REACTIVE PROTEIN, OXIDATIVE STRESS, ENDOTHELIAL FUNCTION
  • Ankara Üniversitesi Adresli: Evet

Özet

Background: Erectile dysfunction (ED) affects 30 million men in the US with a decrease in quality of life. Thirty percent of hypertensive men suffer from ED.